Viatris (VTRS) EBT (2019 - 2026)
Viatris' (VTRS) quarterly EBT came in at -$247.3 million in Q1 2026, up 92.01% year-on-year from -$128.8 million in Q1 2025, and up 27.9% quarter-over-quarter from -$343.0 million in Q4 2025.
Viatris (VTRS) EBT (2019 - 2026) Analysis & Trends
Viatris' EBT history runs 8 years deep, the most recent figure standing at -$247.3 million for Q1 2026.
- On a quarterly basis, EBT rose 92.01% year-over-year to -$247.3 million in Q1 2026; TTM through Mar 2026 was -$815.3 million, a 79.23% increase from a year earlier, with the FY2025 full-year figure at -$3.7 billion, down 488.09% from the prior year.
- EBT advanced to -$247.3 million in Q1 2026 per VTRS's latest filing, from -$343.0 million in the prior quarter.
- Across five years, EBT topped out at $1.5 billion in Q4 2022 and bottomed at -$3.1 billion in Q1 2025.
- The 5-year median for EBT is $90.5 million (2024), against an average of -$89.4 million.
- Across the five-year window, EBT jumped 820.4% in 2022 and slumped 1613.69% in 2025, its largest moves.
- Year by year, EBT stood at $1.5 billion in 2022, then slumped by 158.21% to -$855.0 million in 2023, then soared by 38.42% to -$526.5 million in 2024, then jumped by 34.85% to -$343.0 million in 2025, then climbed by 27.9% to -$247.3 million in 2026.
- Per Business Quant, the three latest VTRS EBT figures stand at -$247.3 million (Q1 2026), -$343.0 million (Q4 2025), and -$7.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247.30 Mn |
| Dec 31, 2025 | -343.00 Mn |
| Sep 30, 2025 | -7.90 Mn |
| Jun 30, 2025 | -217.10 Mn |
| Mar 31, 2025 | -3.10 Bn |
| Dec 31, 2024 | -526.50 Mn |
| Sep 30, 2024 | 90.50 Mn |
| Jun 30, 2024 | -391.80 Mn |
| Mar 31, 2024 | 204.60 Mn |
| Dec 31, 2023 | -855.00 Mn |
| Sep 30, 2023 | 402.20 Mn |
| Jun 30, 2023 | 333.00 Mn |
| Mar 31, 2023 | 322.70 Mn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 427.50 Mn |
| Jun 30, 2022 | 389.30 Mn |
| Mar 31, 2022 | 527.50 Mn |
| Dec 31, 2021 | -203.90 Mn |
| Sep 30, 2021 | 199.90 Mn |
| Jun 30, 2021 | -219.10 Mn |